Src kinases in Ph+ lymphoblastic leukemia.
Deininger
Michael
M
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002051:Burkitt Lymphoma / Q000201:enzymology* / Q000473:pathology; D002455:Cell Division / Q000187:drug effects; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000201:enzymology* / Q000473:pathology; D051379:Mice; D019061:src-Family Kinases / Q000502:physiology*
D000970:Antineoplastic Agents; D019061:src-Family Kinases